Hycamtin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0078-0674

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hycamtin (NDC 0078-0674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topotecan Hydrochloride Chemical Structure (Hycamtin Injection Spl Graphic 01)

FDA Label Image

Figure 1. Overall Survival Curves Comparing Hycamtin Plus Cisplatin Versus Cisplatin Monotherapy In Cervical Cancer Patients (Hycamtin Injection Spl Graphic 02)

FDA Label Image

Hycamtin Injection Label (Hycamtin Injection Spl Graphic 03)

Hycamtin Injection Label (Hycamtin Injection Spl Graphic 03)
HYCAMTIN® is a medication available in single-dose vials for injection. The active ingredient in Hycamtin is topotecan. The manufacturer of this medication is Novartis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.